• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Liberia - Lassa fever outbreak 2022

Pathfinder

Editor, Senior Moderator
WEEKLY BULLETIN ON OUTBREAKS
AND OTHER EMERGENCIES

Week 31: 25 - 31 July 2022
Data as reported by: 17:00; 31 July 2022

...
All events currently being monitored by WHO AFRO
...
Liberia Lassa Fever Ungraded

Date notified to WCO 03-Mar-22
Start of reporting period 06-Jan-22
End of reporting period 27-Jul-22

Total cases 30
Cases Confirmed 30
Deaths 8
CFR 26.7%


Since the beginning of 2022 up to 27 July 2022, a total of 89 suspected cases of Lassa fever including 30 confirmed and 8 deaths (CFR 26.7%) have been reported in Liberia. Two Counties are currently in an outbreak: Grand Bassa and Bong Counties.

https://apps.who.int/iris/bitstream/...2531072022.pdf
 
WEEKLY BULLETIN ON OUTBREAKS
AND OTHER EMERGENCIES


Week 44: 24 to 30 October 2022
Data as reported by: 17:00; 30 October 2022

...

All events currently being monitored by WHO AFRO
...

Liberia Lassa Fever Ungraded

Date notified to WCO 03-Mar-22
Start of reporting period 06-Jan-22
End of reporting period 23-Oct-22

Total cases 52
Cases Confirmed 52
Deaths 17

CFR 32.7%

Since the beginning of 2022 up to 23 October 2022, a total of 156 suspected cases of Lassa fever including 52 laboratory confirmed and 17 deaths among confirmed
cases (CFR 33%) have been reported in Liberia.

...
https://apps.who.int/iris/bitstream/handle/10665/364078/OEW44-2430102022.pdf
 
WEEKLY BULLETIN ON OUTBREAKS
AND OTHER EMERGENCIES

Week 50: 5 - 11 December 2022
Data as reported by: 17:00; 11 December 2022

...

Lassa fever Liberia

67 cases
22 Deaths
32.8% CFR


EVENT DESCRIPTION

Confirmed cases of Lassa fever have previously been reported in
Liberia for more than six years. In 2021, the country experienced
a total of 12 outbreaks of Lassa fever including 25 laboratory
confirmed cases with 16 deaths accounting for a 64.0% case
fatality ratio (CFR). These outbreaks generated a total of 325
contacts of which 196 were healthcare workers. Between 2016
and 2020, a total of 165 confirmed cases including 66 deaths
were reported (CFR 40.0%) in seven out of the 15 counties in
Liberia.

Since early January to 1 December 2022, the country has
experienced seven outbreaks amounting to 67 laboratory
confirmed cases including 22 deaths (CFR 32.8%). A total of
669 contacts were recorded including 344(51.4%) healthcare
workers, of which 5 (1.0%) became confirmed cases.

Of the 15 counties in Liberia, five have reported confirmed cases.
The most affected counties are Bong (22 cases, four deaths),
Grand Bassa (26 cases, six deaths), and Nimba (17 cases, 11
deaths). Montserrado and River Gee counties have each reported
one confirmed case with one death in River Gee County.

Of the 67 confirmed cases, nearly half are males (49.3%).
The most affected age group is 15-29 years old with 26 cases
(38.8%), followed by the under-15 years age group with 22 cases
(32.8%), 30-44 years old with 15 cases (22.4%), and 45 years
old and older with four cases (6.0%). The majority of confirmed
cases are students.

PUBLIC HEALTH ACTIONS

Since the outbreaks of 2022, response measures have been put
in place, including surveillance and laboratory testing, vector
surveillance and control, case management, etc. The National
Public Health Institute of Liberia and the Ministry of Health are
providing technical and logistical support to County Health Teams
with support from partners. Below are the details of the actions
taken in the current outbreak:

Active case finding and contact tracing are ongoing in
affected communities and districts

Development and dissemination of weekly situation reports
by affected counties

Integrated Disease Surveillance and Response 3rd edition
trainings have been conducted in affected counties

The National Public Health Reference Laboratory continues
testing Lassa fever samples

Cases isolation and management at designated facilities

Ongoing clean-up campaigns and rodent control measures
in affected counties (Bong, Grand Bassa, and Nimba)

Risk communication and community engagement are
ongoing in affected and surrounding communities. Airing
of jingles on Lassa fever prevention and control in Bong,
Nimba, and Grand Bassa Counties is underway.

SITUATION INTERPRETATION

Liberia is one of the West African countries where Lassa fever is
endemic along with Benin, Ghana, Guinea, Nigeria, Mali, Sierra
Leone, and Togo. The CFR has halved in 2022 (32.8%) compared
to 2021 (64.0%). This may be attributed to improved case
management as a result of the availability of injectable Ribavirin
medicine procured by WHO and prepositioned to district level
hospitals in all counties reporting suspected and confirmed
cases. However, efforts still need to be made for an earlier arrival
of cases at health facilities for earlier case management, which
could contribute to further reducing the number of deaths.

https://apps.who.int/iris/bitstream/handle/10665/365336/OEW50-0511122022.pdf
 
Back
Top